参考文献/References:
[1] 付畅, 史大鹏, 徐俊玲, 等.不同组织学类型肺癌患者大脑静息葡萄糖代谢改变研究[J]. 国际放射医学核医学杂志, 2014, 38(2):75-79.
[2] Pirl WF, Traeger L, Greer JA, et al. Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer[J]. Palliat Support Care, 2013, 11(3):223-229.
[3] 苏亮, 左传涛, 管一晖, 等. 18F-FDG PET脑显像用于恶性肿瘤患者抑郁分析[J]. 中华核医学杂志, 2005, 25(3):159-161.
[4] 倪建明, 张追阳, 黄钢. 体部恶性肿瘤静息脑葡萄糖代谢改变与肿瘤类型的关系[J]. 临床放射学杂志, 2012, 31(5):627-631.
[5] 林盟菲, 黄钢, 孙晓光, 等. 肺癌患者脑代谢改变与分期的关系[J]. 中国临床医学, 2009, 16(4):516-518.
[6] Lloyd-Williams M, Cobb M, O’connor C, et al. A pilot randomised controlled trial to reduce suffering and emotional distress in patients with advanced cancer[J]. J Affect Disord, 2013, 148(1):141-145.
[7] Fujimoto T, Takeuchi K, Matsumoto T, et al. Metabolic changes in the brain of patients with late-onset major depression[J]. Psychiatry Res, 2008, 164(1):48-57.
[8] Kim LS, Hwang HS, Jon DI, et al. Dysfunction of the neural network associated with sustained attention in cancer patients with clinically significant depressive symptoms[J]. Neurosci Lett, 2008, 447(1):1-6.
[9] 倪建明, 刘建军, 林盟菲, 等. 胰腺癌患者大脑静息葡萄糖代谢变化研究[J]. 中国医学计算机成像杂志, 2009, 15(6):561-565.
[10] Inagaki M, Yoshikawa E, Kobayakawa M, et al. Regional cerebral glucose metabolism in patients with secondary depressive episodes after fatal pancreatic cancer diagnosis[J]. J Affect Disord, 2007, 99(1/3):231-236.
[11] Miller AH, Ancoli-Israel S, Bower JE, et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer[J]. J Clin Oncol, 2008, 26(6):971-982.
[12] O’keane V, Frodl T, Dinan TG. A review of Atypical depression in relation to the course of depression and changes in HPA axis organization[J]. Psychoneuroendocrinology, 2012, 37(10):1589-1599.
[13] Ionescu DN, Treaba D, Gilks CB, et al. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance[J]. Am J Surg Pathol, 2007, 31(1):26-32.
[14] Bremnes RM, Al-Shibli K, Donnem T, et al. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis:emphasis on non-small cell lung cancer[J]. J Thorac Oncol, 2011, 6(4):824-833.
[15] Rausch SM, Gonzalez BD, Clark MM, et al. SNPs in PTGS2 and LTA predict pain and quality of Life in long term lung cancer survivors[J]. Lung Cancer, 2012, 77(1):217-223.
[16] Reyes-Gibby CC, Wang J, Spitz M, et al. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients[J]. J Pain Symptom Manage, 2013, 46(2):161-172.